Apogee Enterprises (APOG) director settles 2,883 deferred units to stock

Rhea-AI Filing Summary

Apogee Enterprises director Lloyd Emerson Johnson reported settling deferred restricted stock units into common shares. On January 2, 2026, he converted 2,883 deferred restricted stock units into the same number of Apogee common shares under the company’s non-employee director stock plans, in line with his prior election under the plan.

After this settlement, Johnson directly holds 10,014 shares of common stock and 19,111 deferred restricted stock units, which will be settled in stock after he leaves the board or upon other plan events. The transaction was reported as a code “M” (exercise or conversion) with a reported price of $0.00 per unit and share, reflecting the nature of the deferred stock unit settlement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Lloyd Emerson

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MN 55435

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		M		2,883	A	(1)	10,014	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Restricted Stock Units	(2)	01/02/2026		M		2,883		(3)	01/02/2026	Common Stock	2,883	(1)	19,111	D

Explanation of Responses:

1. The deferred restricted stock units were settled in shares of common stock in accordance with the election of the reporting person as specified in the Plan.

2. Settled -1 for -1.

3. The deferred restricted stock units were allocated under the 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.

Remarks:

	/s/Meghan M. Elliott, Attorney-in-Fact for Lloyd E. Johnson	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did APOG report for Lloyd Emerson Johnson on January 2, 2026?

Apogee Enterprises reported that director Lloyd Emerson Johnson settled 2,883 deferred restricted stock units into 2,883 shares of common stock on January 2, 2026. The transaction was coded “M,” indicating a conversion of derivative securities into common stock.

How many Apogee (APOG) common shares does Lloyd Emerson Johnson own after this Form 4 transaction?

Following the reported transaction, Lloyd Emerson Johnson directly owns 10,014 shares of Apogee common stock as shown in the Form 4.

What happens to the remaining deferred restricted stock units reported for APOG director Lloyd Emerson Johnson?

After the settlement of 2,883 units, Lloyd Emerson Johnson holds 19,111 deferred restricted stock units. According to the disclosure, these units will be settled in shares of common stock after his termination from the board or upon other events specified in the applicable stock plans and his prior election.

Under which Apogee Enterprises plans were the deferred restricted stock units granted to Lloyd Emerson Johnson?

The deferred restricted stock units were allocated under Apogee’s 2009 Non-Employee Director Stock Incentive Plan and the 2019 Non-Employee Director Stock Plan, as described in the footnotes.

Did Lloyd Emerson Johnson pay a cash exercise price for the Apogee deferred restricted stock units converted on January 2, 2026?

The Form 4 reports a price of $0.00 per unit and per share for the January 2, 2026 transaction, consistent with a settlement of deferred restricted stock units into common shares without a cash exercise price.

What does transaction code "M" mean in Lloyd Emerson Johnson’s Apogee (APOG) Form 4 filing?

In this filing, transaction code “M” indicates that deferred restricted stock units were converted or settled into common stock. Specifically, 2,883 deferred units were settled into 2,883 common shares of Apogee Enterprises.